These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 32017680)

  • 41. CBD-enriched cannabis for autism spectrum disorder: an experience of a single center in Turkey and reviews of the literature.
    Bilge S; Ekici B
    J Cannabis Res; 2021 Dec; 3(1):53. PubMed ID: 34911567
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ
    Boggs DL; Nguyen JD; Morgenson D; Taffe MA; Ranganathan M
    Neuropsychopharmacology; 2018 Jan; 43(1):142-154. PubMed ID: 28875990
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evidence for cannabis and cannabinoids for epilepsy: a systematic review of controlled and observational evidence.
    Stockings E; Zagic D; Campbell G; Weier M; Hall WD; Nielsen S; Herkes GK; Farrell M; Degenhardt L
    J Neurol Neurosurg Psychiatry; 2018 Jul; 89(7):741-753. PubMed ID: 29511052
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of CBD-enriched medical cannabis for treatment of refractory epilepsy in children and adolescents - An observational, longitudinal study.
    Hausman-Kedem M; Menascu S; Kramer U
    Brain Dev; 2018 Aug; 40(7):544-551. PubMed ID: 29674131
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cannabidiol as a suggested candidate for treatment of autism spectrum disorder.
    Poleg S; Golubchik P; Offen D; Weizman A
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 89():90-96. PubMed ID: 30171992
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Could Cannabidiol be a Treatment Option for Intractable Childhood and Adolescent Epilepsy?
    Koo CM; Kang HC
    J Epilepsy Res; 2017 Jun; 7(1):16-20. PubMed ID: 28775950
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Pharmacological Basis of Cannabis Therapy for Epilepsy.
    Reddy DS; Golub VM
    J Pharmacol Exp Ther; 2016 Apr; 357(1):45-55. PubMed ID: 26787773
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of CBD-Enriched
    Fleury-Teixeira P; Caixeta FV; Ramires da Silva LC; Brasil-Neto JP; Malcher-Lopes R
    Front Neurol; 2019; 10():1145. PubMed ID: 31736860
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of the efficacy and safety of cannabidiol-rich cannabis extract in children with autism spectrum disorder: randomized, double-blind, and placebo-controlled clinical trial.
    Silva EAD; Medeiros WMB; Santos JPMD; Sousa JMM; Costa FBD; Pontes KM; Borges TC; Espínola C; Andrade E Silva AH; Nunes ELG; Alves NT; Rosa MDD; Albuquerque KLGD
    Trends Psychiatry Psychother; 2024; 46():e20210396. PubMed ID: 35617670
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Heat exposure of Cannabis sativa extracts affects the pharmacokinetic and metabolic profile in healthy male subjects.
    Eichler M; Spinedi L; Unfer-Grauwiler S; Bodmer M; Surber C; Luedi M; Drewe J
    Planta Med; 2012 May; 78(7):686-91. PubMed ID: 22411724
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cannabinoid therapy in epilepsy.
    Billakota S; Devinsky O; Marsh E
    Curr Opin Neurol; 2019 Apr; 32(2):220-226. PubMed ID: 30676535
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study.
    Vaney C; Heinzel-Gutenbrunner M; Jobin P; Tschopp F; Gattlen B; Hagen U; Schnelle M; Reif M
    Mult Scler; 2004 Aug; 10(4):417-24. PubMed ID: 15327040
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Medical cannabis for the treatment of comorbid symptoms in children with autism spectrum disorder: An interim analysis of biochemical safety.
    Stolar O; Hazan A; Vissoker RE; Kishk IA; Barchel D; Lezinger M; Dagan A; Treves N; Meiri D; Berkovitch M; Kohn E; Heyman E
    Front Pharmacol; 2022; 13():977484. PubMed ID: 36249785
    [No Abstract]   [Full Text] [Related]  

  • 54. Cannabinoids: from pot to lab.
    Papaseit E; Pérez-Mañá C; Pérez-Acevedo AP; Hladun O; Torres-Moreno MC; Muga R; Torrens M; Farré M
    Int J Med Sci; 2018; 15(12):1286-1295. PubMed ID: 30275754
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cannabidiol and the Remainder of the Plant Extract Modulate the Effects of Δ9-Tetrahydrocannabinol on Fear Memory Reconsolidation.
    Murkar A; Kent P; Cayer C; James J; Durst T; Merali Z
    Front Behav Neurosci; 2019; 13():174. PubMed ID: 31417379
    [No Abstract]   [Full Text] [Related]  

  • 56. Fast Detection of 10 Cannabinoids by RP-HPLC-UV Method in
    Mandrioli M; Tura M; Scotti S; Gallina Toschi T
    Molecules; 2019 Jun; 24(11):. PubMed ID: 31167395
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Placebo-Controlled Trial of Cannabinoid Treatment for Disruptive Behavior in Children and Adolescents with Autism Spectrum Disorder: Effects on Sleep Parameters as Measured by the CSHQ.
    Schnapp A; Harel M; Cayam-Rand D; Cassuto H; Polyansky L; Aran A
    Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35884990
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Probing the antioxidant activity of Δ
    Hacke ACM; Lima D; de Costa F; Deshmukh K; Li N; Chow AM; Marques JA; Pereira RP; Kerman K
    Analyst; 2019 Aug; 144(16):4952-4961. PubMed ID: 31318364
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Determination of cannabinoids in cannabis products using liquid chromatography-ion trap mass spectrometry.
    Stolker AA; van Schoonhoven J; de Vries AJ; Bobeldijk-Pastorova I; Vaes WH; van den Berg R
    J Chromatogr A; 2004 Nov; 1058(1-2):143-51. PubMed ID: 15595662
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.